Placental extracellular vesicles and feto-maternal communication

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 3, 2015, Pages

  Tong, M ^a   Chamley, L W ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DNA; FAS LIGAND; HLA G ANTIGEN; MESSENGER RNA; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PROGRAMMED DEATH 1 LIGAND 1; SPHINGOMYELIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; LIPID; NUCLEIC ACID;

APOPTOSIS; ARTICLE; CELL BUDDING; CELL MEMBRANE; CELL VACUOLE; EMBRYONIC AND PLACENTAL STRUCTURES; ENDOSOME; ENDOTHELIUM CELL; EXOSOME; GESTATIONAL AGE; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE; MACROPHAGE; MATERNAL BLOOD; MICROVILLUS; MONOCYTE; NEUTROPHIL; NONHUMAN; PLACENTA; PREECLAMPSIA; SYNCYTIAL NUCLEAR AGGREGATE; SYNCYTIOTROPHOBLAST; TROPHOBLAST; FEMALE; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY;

EXTRACELLULAR VESICLES; FEMALE; HUMANS; LIPIDS; MATERNAL-FETAL EXCHANGE; NUCLEIC ACIDS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 84923876658     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a023028     Document Type: Article

References (87)

1. Abrahams VM, Straszewski-Chavez SL, Guller S, Mor G. 2004. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 10: 55-63.
2. Abumaree MH, Stone PR, Chamley LW. 2006. The effects of apoptotic, deported human placental trophoblast on macrophages: Possible consequences for pregnancy. JRe-prod Immunol 72: 33-45.
3. Abumaree MH, Chamley LW, Badri M, El-Muzaini MF. 2012. Trophoblast debris modulates the expression of immune proteins in macrophages: A key to maternal tolerance of the fetal allograft? J Reprod Immunol 94: 131-141.
4. Aharon A, Katzenell S, Tamari T, Brenner B. 2009. Micro-particles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications. J Thromb Haemost 7: 1047-1050.
5. Alijotas-Reig J, Palacio-Garcia C, Vilardell-Tarres M. 2009. Circulating microparticles, lupus anticoagulant and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol 145: 22-26.
6. Aly AS, Khandelwal M, Zhao J, Mehmet AH, Sammel MD, Parry S. 2004. Neutrophils are stimulated by syncytiotro-phoblast microvillous membranes to generate superoxide radicals in women with preeclampsia. Am JObstet Gyne-col 190: 252-258.
7. Asea A, Jean-Pierre C, Kaur P, Rao P, Linhares IM, Skupski D, Witkin SS. 2008. Heat shock protein-containing exo-somes in mid-trimester amniotic fluids. J Reprod Immunol 79: 12-17.
8. Atay S, Gercel-Taylor C, Suttles J, Mor G, Taylor DD. 2011a. Trophoblast-derived exosomes mediate monocyte recruitment and differentiation. Am J Reprod Immunol 65: 65-77.
9. Atay S, Gercel-Taylor C, Taylor DD. 2011b. Human tropho-blast-derived exosomal fibronectin induces pro-inflammatory IL-1fS production by macrophages. Am J Reprod Immunol 66: 259-269.
10. Attwood HD, Park WW. 1961. Embolism to the lungs by trophoblast. J Obstet Gynaecol Br Commonw 68:611-617.
11. Baig S, Lim JY, Fernandis AZ, Wenk MR, Kale A, Su LL, Biswas A, Vasoo S, Shui G, Choolani M. 2013. Lipidomic analysis of human placental syncytiotrophoblast micro-vesicles in adverse pregnancy outcomes. Placenta 34: 436-442.
12. Bischoff FZ, Lewis DE, Simpson JL. 2005. Cell-free fetal DNA in maternal blood: Kinetics, source and structure. Hum Reprod Update 11: 59-67.
13. Buurma AJ, Penning ME, Prins F, Schutte JM, Bruijn JA, Wilhelmus S, Rajakumar A, Bloemenkamp KW, Karu-manchi SA, Baelde HJ. 2013. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung. Hypertension 62: 608-613.
14. Brosens I, Robertson WB, Dixon HG. 1967. The physiological response ofthe vessels ofthe placental bed to normal pregnancy. J Pathol Bacteriol 93(2): 569-579.
15. Chamley LW, Holland OJ, Chen Q, Viall CA, Stone PR, Abumaree M. 2014. Review: Where is the maternofetal interface? Placenta 35: S74-S80.
16. Chen Q, Stone PR, McCowan LM, Chamley LW. 2006. Phagocytosis of necrotic but not apoptotic trophoblasts induces endothelial cell activation. Hypertension 47: 116-121.
17. Chen Q, Stone P, Ching LM, Chamley L. 2009. A role for interleukin-6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: Implications for the pathogenesis ofpre-eclampsia. JPathol 217: 122-130.
18. Chen Q, Ding JX, Liu B, Stone P, Feng YJ, Chamley L. 2010. Spreading endothelial cell dysfunction in response to ne-crotic trophoblasts. Soluble factors released from endo-thelial cells that have phagocytosed necrotic shed tropho-blasts reduce the proliferation of additional endothelial cells. Placenta 31: 976-981.
19. Chen Q, Guo F, Jin HY, Lau S, Stone P, Chamley L. 2012a. Phagocytosis of apoptotic trophoblastic debris protects endothelial cells against activation. Placenta 33: 548-553.
20. Chen Y, Huang Y, Jiang R, Teng Y. 2012b. Syncytiotropho-blast-derived microparticle shedding in early-onset and late-onset severe pre-eclampsia. Int J Gynaecol Obstet 119: 234-238.
21. Chen Q, Tong M, Wu M, Stone PR, Snowise S, Chamley LW. 2013. Calcium supplementation prevents endothelial cell activation: Possible relevance to preeclampsia. J Hypertens 31: 1828-1836.
22. Chua S, Wilkins T, Sargent I, Redman C. 1991. Trophoblast deportation in pre-eclamptic pregnancy. Br JObstet Gynaecol 98: 973-979.
23. Cockell AP, Learmont JG, Smarason AK, Redman CW, Sargent IL, Poston L. 1997. Human placental syncytiotro-phoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol 104: 235-240.
24. Colucci G, Pesenti E, Molteni E, Lobbiani A, De Andreis C, Pariani S, Rossella F, Semprini AE, Simoni G. 1993. Applicability of DNA isolated from syncytiotrophoblast vesicles to gene amplification and molecular analysis. PrenatDiagn 13: 335-340.
25. Covone AE, Mutton D, Johnson PM, Adinolfi M. 1984. Trophoblast cells in peripheral blood from pregnant women. Lancet 2(8407): 841-843.
26. Cronqvist T, Salje K, Familari M, Guller S, Schneider H, Gardiner C, Sargent IL, Redman CW, Morgelin M, Aker-strom B, et al. 2014. Syncytiotrophoblast vesicles show altered micro-RNA and haemoglobin content after ex-vivo perfusion of placentas with haemoglobin to mimic preeclampsia. PLoS ONE 9: e90020.
27. Degenne D, Thibault G, Guillaumin JM, Lacord M, Bardos P. 1991. Syncytiotrophoblast plasma membrane inhibits membrane expression of activation markers on PHA-stimulated human lymphocytes. J Reprod Immunol 20: 183-187.
28. Delorme-Axford E, Donker RB, Mouillet JF, Chu T, Bayer A, Ouyang Y, Wang T, Stolz DB, Sarkar SN, Morelli AE, et al. 2013. Human placental trophoblasts confer viral resistance to recipient cells. Proc Natl Acad Sci 110: 12048-12053.
29. Donker RB, Mouillet JF, Chu T, Hubel CA, Stolz DB, Morelli AE, Sadovsky Y 2012. The expression profile of C19MC microRNAs in primaryhuman trophoblast cells and exo-somes. Mol Hum Reprod 18: 417-424.
30. Frangsmyr L, Baranov V, Nagaeva O, Stendahl U, Kjellberg L, Mincheva-Nilsson L. 2005. Cytoplasmic microvesicu-lar form ofFas ligand in human earlyplacenta: Switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol Hum Reprod 11: 35-41.
31. Gardiner C, Tannetta DS, Simms CA, Harrison P, Redman CW, Sargent IL. 2011. Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity. PLoS ONE 6: e26313.
32. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. 2007. Systemic inflammatory priming in normal pregnancy and preeclampsia: The role ofcirculating syn-cytiotrophoblast microparticles. J Immunol 178: 59495956.
33. Goswami D, Tannetta DS, Magee LA, Fuchisawa A, Redman CW, Sargent IL, von Dadelszen P. 2006. Excess syncytio-trophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 27: 56-61.
34. Guller S, Tang Z, Ma YY, Di Santo S, Sager R, Schneider H. 2011. Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia. Placenta 32: 63-69.
35. Gupta AK, Holzgreve W, Huppertz B, Malek A, Schneider H, Hahn S. 2004. Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro. Clin Chem 50: 2187-2190.
36. Gupta AK, Hasler P, Holzgreve W, Gebhardt S, Hahn S. 2005a. Induction ofneutrophil extracellular DNAlattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum Immunol 66: 1146-1154.
37. Gupta AK, Rusterholz C, Holzgreve W, Hahn S. 2005b. Syncytiotrophoblast micro-particles do not induce apoptosis in peripheral T lymphocytes, but differ in their activity depending on the mode of preparation. J Reprod Immunol 68: 15-26.
38. Gupta AK, Rusterholz C, Huppertz B, Malek A, Schneider H, Holzgreve W, Hahn S. 2005c. A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells. Placenta 26: 59-66.
39. Gupta AK, Holzgreve W, Hahn S. 2008. Decrease in lipid levels of syncytiotrophoblast micro-particles reduced their potential to inhibit endothelial cell proliferation. Arch Gynecol Obstet 277: 115-119.
40. Hedlund M, Stenqvist AC, Nagaeva O, Kjellberg L, Wulff M, Baranov V, Mincheva-Nilsson L. 2009. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: Evidence for immunosuppressive function. J Immunol 183: 340-351.
41. Hoegh AM, Tannetta D, Sargent I, Borup R, Nielsen FC, Redman C, Sorensen S, Hviid TV. 2006. Effect of syncy-tiotrophoblast microvillous membrane treatment on gene expression in human umbilical vein endothelial cells. BJOG 113: 1270-1279.
42. Holder BS, Tower CL, Forbes K, Mulla MJ, Aplin JD, Abrahams VM. 2012a. Immune cell activation bytrophoblast-derived microvesicles is mediated by syncytin 1. Immunology 136: 184-191.
43. Holder BS, Tower CL, Jones CJ, Aplin JD, Abrahams VM. 2012b. Heightened pro-inflammatory effect of pre-eclamptic placental microvesicles on peripheral blood immune cells in humans. Biol Reprod 86: 103.
44. Holland OJ, Linscheid C, Hodes HC, Nauser TL, Gilliam M, Stone P, Chamley LW, Petroff MG. 2012. Minor histo-compatibility antigens are expressed in syncytiotropho-blast and trophoblast debris: Implications for maternal alloreactivity to the fetus. Am J Pathol 180: 256-266.
45. Keller S, Ridinger J, Rupp AK, Janssen JW, Altevogt P. 2011. Body fluid derived exosomes as a novel template for clinical diagnostics. JTransl Med 9: 86.
46. Khalfoun B, Degenne D, Crouzat-Reynes G, Bardos P. 1986. Effect of human syncytiotrophoblast plasma membrane-soluble extracts on in vitro mitogen-induced lymphocyte proliferation. A possible inhibition mechanism involving the transferrin receptor. J Immunol 137: 1187-1193.
47. Knight M, Redman CW, Linton EA, Sargent IL. 1998. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br JObstet Gynaecol 105: 632-640.
48. Kowal J, Tkach M, Thery C. 2014. Biogenesis and secretion of exosomes. Curr Opin Cell Biol 29C: 116-125.
49. Kshirsagar SK, Alam SM, Jasti S, Hodes H, Nauser T, Gilliam M, Billstrand C, Hunt JS, Petroff MG. 2012. Immunomodulatory molecules are released from the first trimester and term placenta via exosomes. Placenta 33: 982990.
50. Lapaire O, Holzgreve W, Oosterwijk JC, Brinkhaus R, Bian-chi DW. 2007. Georg Schmorl on trophoblasts in the maternal circulation. Placenta 28: 1-5.
51. Lee SM, Romero R, Lee YJ, Park IS, Park CW, Yoon BH. 2012. Systemic inflammatory stimulation by microparti-cles derived from hypoxic trophoblast as a model for inflammatory response in preeclampsia. Am J Obstet Gynecol 207: 337 e331-e338.
52. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, et al. 2004. Circulating angiogenic factors and the risk of preeclampsia. N Engl JMed 350: 672-683.
53. Lok CA, Boing AN, Sargent IL, Sooranna SR, van der Post JA, Nieuwland R, Sturk A. 2008a. Circulating platelet-derived and placenta-derived microparticles expose Flt-1 in preeclampsia. Reprod Sci 15: 1002-1010.
54. Lok CA, Van Der Post JA, Sargent IL, Hau CM, Sturk A, Boer K, Nieuwland R. 2008b. Changes in microparticle numbers and cellular origin during pregnancy and pre-eclampsia. Hypertens Pregnancy 27: 344-360.
55. Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T, Takizawa T, Shigihara T, Goto T, Izumi A, et al. 2009. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod 81: 717-729.
56. Mayhew T.M. 2014. Turnover ofhuman villous trophoblast in normal pregnancy: What do we know and what do we need to know? Placenta 35(4): 229-240.
57. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, et al. 2003. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658.
58. Messerli M, May K, Hansson SR, Schneider H, Holzgreve W, Hahn S, Rusterholz C. 2010. Feto-maternal interactions in pregnancies: Placental microparticles activate peripheral blood monocytes. Placenta 31: 106-112.
59. Mincheva-Nilsson L, Nagaeva O, Chen T, Stendahl U, Ant-siferova J, Mogren I, Hernestal J, Baranov V. 2006. Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: A possible novel immune escape mechanism for fetal survival. JImmunol 176: 3585-3592.
60. O'Sullivan MJ, McIntyre JA, Prior M, Warriner G, Faulk WP. 1982. Identification of human trophoblast membrane antigens in maternal blood during pregnancy. Clin Exp Immunol 48: 279-287.
61. Omatsu K, Kobayashi T, Murakami Y, Suzuki M, Ohashi R, Sugimura M, Kanayama N. 2005. Phosphatidylserine/ phosphatidylcholine microvesicles can induce pre-eclampsia-like changes in pregnant mice. Semin Thromb Hemost 31: 314-320.
62. Orozco AF, Jorgez CJ, Horne C, Marquez-Do DA, Chapman MR, Rodgers JR, Bischoff FZ, Lewis DE. 2008. Membrane protected apoptotic trophoblast microparticles contain nucleic acids: Relevance to preeclampsia. Am J Pathol 173: 1595-1608.
63. Orozco AF, Jorgez CJ, Ramos-Perez WD, Popek EJ, Yu X, Kozinetz CA, Bischoff FZ, Lewis DE. 2009. Placental release of distinct DNA-associated micro-particles into maternal circulation: Reflective of gestation time and pre-eclampsia. Placenta 30: 891-897.
64. Pap E, Pallinger E, Falus A, Kiss AA, Kittel A, Kovacs P, Buzas EI. 2008. T lymphocytes are targets for plateletand tro-phoblast-derived microvesicles during pregnancy. Placenta 29: 826-832.
65. Park WW. 1975. Possible functions of nonvillous trophoblast. Eur J Obstet Gynecol Reprod Biol 5: 35-46.
66. Rajakumar A, Cerdeira AS, Rana S, Zsengeller Z, Edmunds L, Jeyabalan A, Hubel CA, Stillman IE, Parikh SM, Karumanchi SA. 2012. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in pre-eclampsia. Hypertension 59: 256-264.
67. Rana S, Zoller M. 2011. Exosome target cell selection and the importance of exosomal tetraspanins: A hypothesis. Biochem Soc Trans 39: 559-562.
68. Rana S, Yue S, Stadel D, Zoller M. 2012. Toward tailored exosomes: The exosomal tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol 44: 15741584.
69. Raposo G, Stoorvogel W. 2013. Extracellular vesicles: Exo-somes, microvesicles, and friends. J Cell Biol 200: 373-383.
70. Record M, Carayon K, Poirot M, Silvente-Poirot S. 2014. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta 1841: 108-120.
71. Reddy A, Zhong XY, Rusterholz C, Hahn S, Holzgreve W, Redman CW, Sargent IL. 2008. The effect of labour and placental separation on the shedding of syncytiotropho-blast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia. Placenta 29: 942-949.
72. Rusterholz C, Holzgreve W, Hahn S. 2007. Oxidative stress alters the integrity of cell-free mRNA fragments associated with placenta-derived syncytiotrophoblast micropar-ticles. Fetal Diagn Ther 22: 313-317.
73. Sabapatha A, Gercel-Taylor C, Taylor DD. 2006. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol 56: 345-355.
74. Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, Mitchell M, Rice GE. 2013. Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS ONE 8: e68451.
75. Schmorl G. 1893. Pathologisch-AnatomischeUntersuchungen Uber Puerperal-Eklampsie. Verlag von FC Vogel, Leipzig, Germany.
76. Shen F, Wei J, Snowise S, DeSousa J, Stone P, Viall C, Chen Q, Chamley L. 2014. Trophoblast debris extruded from pre-eclamptic placentae activates endothelial cells: A mechanism by which the placenta communicates with the maternal endothelium. Placenta 35: 839-847.
77. Smarason AK, Sargent IL, Starkey PM, Redman CW. 1993. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 100: 943-949.
78. Southcombe J, Tannetta D, Redman C, Sargent I. 2011. The immunomodulatory role of syncytiotrophoblast microvesicles. PLoS ONE 6: e20245.
79. Stenqvist AC, Nagaeva O, Baranov V, Mincheva-Nilsson L. 2013. Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apo-ptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus. J Immunol 191: 5515-5523.
80. Tannetta DS, Dragovic RA, Gardiner C, Redman CW, Sargent IL. 2013. Characterisation of syncytiotrophoblast vesicles in normal pregnancyand pre-eclampsia: Expression of Flt-1 and endoglin. PLoS ONE 8: e56754.
81. Taylor DD, Akyol S, Gercel-Taylor C. 2006. Pregnancy-associated exosomes and their modulation ofT cell signaling. J Immunol 176: 1534-1542.
82. Than NG, Abdul Rahman O, Magenheim R, Nagy B, Fule T, Hargitai B, Sammar M, Hupuczi P, Tarca AL, Szabo G, et al. 2008. Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with pre-term pre-eclampsia and HELLP syndrome. Virchows Archiv 453: 387-400.
83. Thibault G, Degenne D, Girard AC, Guillaumin JM, Lacord M, Bardos P. 1991. The inhibitory effect of human syncytiotrophoblast plasma membrane vesicles on in vitro lymphocyte proliferation is associated with reduced in-terleukin 2 receptor expression. Cell Immunol 138: 165-174.
84. Thibault G, Degenne D, Lacord M, Guillaumin JM, Girard AC, Bardos P. 1992. Inhibitoryeffect ofhuman syncytio-trophoblast plasma membrane vesicles on Jurkat cells activated by phorbol ester and calcium ionophore. Cell Immunol 139: 259-267.
85. Tolosa JM, Schjenken JE, Clifton VL, Vargas A, Barbeau B, Lowry P, Maiti K, Smith R. 2012. The endogenous retro-viral envelope protein syncytin-1 inhibits LPS/PHAstimulated cytokine responses in human blood and is sorted into placental exosomes. Placenta 33: 933-941.
86. Vargas A, Zhou S, Ethier-Chiasson M, Flipo D, Lafond J, Gilbert C, Barbeau B. 2014. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J 28: 3703-3719.
87. von Dadelszen P, Hurst G, Redman CW. 1999. Supernatants from co-cultured endothelial cells and syncytiotropho-blast microvillous membranes activate peripheral blood leukocytes in vitro. Hum Reprod 14: 919-924.